Newron Pharmaceuticals To Present At The 18th Annual BIO CEO & Investor Conference In New York
MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) [Ticker: SIX: NWRN], a research and development company focused on novel central nervous system (CNS) and pain therapies, today announced that Stefan Weber, CEO, will present at the 18th Annual BIO CEO & Investor Conference in New York, NY on Feb. 9, 2016 at 9:00 a.m. ET in the Conrad Room at the Waldorf Astoria New York.